HLA-A*0201 & B2M & Survivin (TLPPAWQPFL)

HLA-A*0201 & B2M & Survivin (TLPPAWQPFL) Liste de produits

Attribut
Protein (2)
Bibliothèque de produits
En ligne (2)
Espèces
Human (2)
Étiquette
His Tag & Avi Tag (1)His Tag (1)
Marqueur
Biotin-labeled (1)PE Labeled (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
HLN-H82E5	Human	HEK293	Biotinylated Human HLA-A*02:01&B2M&Survivin (TLPPAWQPFL) Complex Protein (Monomer, MALS verified)				Ajouter au panier
HLN-HP2H9	Human	HEK293	PE-Labeled Human HLA-A*02:01&B2M&Survivin (TLPPAWQPFL) Tetramer Protein				Ajouter au panier

Quantité totale2

HLA-A*0201 & B2M & Survivin (TLPPAWQPFL)Contexte de la molécule

Survivin, also known as BIRC5 and EPR-1, is a member of the inhibitor of apoptosis (IAP) family, which encodes negative regulatory proteins that prevent apoptotic cell death. IAP family members usually contain multiple baculovirus IAP repeat (BIR) domains, but birc5 encodes proteins with only a single BIR domain. The Human HLA-A*0201 Survivin (TLPPAWQPFL) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M and TLPPAWQPFL peptide of the Survivin.

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
AFX-5931	AFX-5931	Phase 2 Clinical		Eczema	Details
MW-151	MW01-9-034WH; MW-151; MW01-2-151SRM	Phase 1 Clinical	University Of Kentucky	Drug-Related Side Effects and Adverse Reactions; Poisoning; Cognition Disorders	Details
64CU-DOTA-ECL1i		Phase 1 Clinical	Washington University School Of Medicine	Carotid Artery Diseases; Heart Diseases; Arteriosclerosis	Details